Evidence map›Paper›PMID 34250046›Full record

ArticleFrontiers in cardiovascular medicine2021

Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis.

Brett W Sperry, Ashley Bock, Frank P DiFilippo, Joseph P Donnelly, Mazen Hanna, Wael A Jaber

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Preclinical and preliminary clinical evaluation of [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. Imaging of cardiac amyloidosis using dynamicAnnals of nuclear medicine · 2025
    Article
  3. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysis.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2023
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brett W SperryCleveland Clinic Foundation, Kansas City, MO, United States.
Ashley BockCleveland Clinic Foundation, Kansas City, MO, United States.
Frank P DiFilippoCleveland Clinic Foundation, Kansas City, MO, United States.
Joseph P DonnellyCleveland Clinic Foundation, Kansas City, MO, United States.
Mazen HannaCleveland Clinic Foundation, Kansas City, MO, United States.
Wael A JaberCleveland Clinic Foundation, Kansas City, MO, United States.
Cleveland Clinic · USUniversity of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATTRcardiomyopathyflorbetabenlight chain amyloidosispositron emision tomographytechnetium pyrophosphate

Identifiers

PMID34250046
PMCPMC8267881
OpenAlexW3174834306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.